Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection

Clinical trial NCT01203345 · COMPLETED

Trial details

NCT number: NCT01203345
Sponsor: NICHD Neonatal Research Network
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Infant, Newborn Infant, Low Birth Weight Infant, Small for Gestational Age Infant, Premature Sepsis

Start date: 1988-01-01
Primary completion: 1991-03-01
Enrollment: 2416

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.